Drug Shortage Report for CELESTONE SOLUSPAN

Last updated on 2017-05-24 History
Report ID 7806
Drug Identification Number 00028096
Brand name CELESTONE SOLUSPAN
Common or Proper name BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID
Company Name MERCK CANADA INC
Active Ingredient(s) BETAMETHASONE ACETATE BETAMETHASONE
Strength(s) 3MG 3MG
Dosage form(s) SUSPENSION
Route of administration INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR
Packaging size 1mL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-05-01
Actual start date 2017-05-01
Estimated end date 2017-05-24
Actual end date 2017-05-23
Shortage status Resolved
Updated date 2017-05-24
Company comments Resolved
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2017-05-24 English Compare
v11 2017-05-23 French Compare
v10 2017-05-23 English Compare
v9 2017-05-23 French Compare
v8 2017-05-23 English Compare
v7 2017-05-18 French Compare
v6 2017-05-18 English Compare
v5 2017-05-03 French Compare
v4 2017-05-03 English Compare
v3 2017-05-02 English Compare
v2 2017-04-24 French Compare
v1 2017-04-24 English Compare